Académique Documents
Professionnel Documents
Culture Documents
159]
For correspondence:
Dr. Karuna Singh,
Department of Radiotherapy and Oncology,
All India Institute of Medical Sciences,
New Delhi - 110 029, India.
Figure 3: The computerized tomography scan of the orbit showing the E-mail: karuna.mamc@gmail.com
evidence of a 2 cm growth on the medial canthus eroding the walls of
maxilla and nasal wall
REFERENCES
Ophthalmologic intervention can be done in patients who have
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM.
a vision threatening episode due to mass effect. Chemotherapy
Estimates of worldwide burden of cancer in 2008. Int J Cancer
being a systemic therapy can be prescribed in these advanced 2010;127:2893-917.
stage diseases, and radiotherapy is reserved for palliative 2. Shields CL, Shields JA, Peggy M. Tumors metastatic to the orbit.
purposes. A significant number of patients present with Ophthal Plast Reconstr Surg 1988;4:73-80.
ocular symptoms first without any evidence of other systemic 3. Gosslee JM, Misra RP, Langford MP, Vikovius B, Byrd WA, Flynn SB.
complaints.[4] A high index of suspicion on the part of clinician Orbital metastasis of keratinizing squamous cell carcinoma with
giant cells. Int Ophthalmol 2009;29:39-44.
is therefore required to detect such case at earliest stage.
4. Mcculley TJ, Yip CC, Bullock JD, Warwar RE, Hood DL. Cervical
carcinoma metastatic to the orbit. Ophthal Plast Reconstr Surg
Screening for carcinoma cervix might be useful as a part of 2002;5:385-7.
systemic evaluation in patients who presented with orbital 5. Lee HM, Choo CT, Poh WT. Orbital metastasis from carcinoma cervix.
metastasis with unknown primary in females.[5] Br J Ophthalmol 1997;4:330-1.
358 Journal of Cancer Research and Therapeutics - July-September 2011 - Volume 7 - Issue 3
[Downloaded free from http://www.cancerjournal.net on Wednesday, April 10, 2019, IP: 36.84.243.159]
Figure 1: (a and b) CT chest showing mass in the right lung (arrow) and right pleural effusion (*)
90/ min, blood pressure of 130/80 mmHg, pallor and there was Table 1: Classification of agents (By IARC Monographs,
no lymph node enlargement. Respiratory system examination Volumes 1-100)
revealed diminished breath sounds and dull percussion note in Group Category Agents
1 Carcinogenic to humans 107
the right axillary, right infrascapular area and there were no
2A Probably carcinogenic to humans 58
added sounds. Abdominal examination showed hepatomegaly 2B Possibly carcinogenic to humans 249
and other system examination were normal. 3 Not classifiable as to its carcinogenicity 512
to humans
4 Probably not carcinogenic to humans 1
Laboratory examination revealed normal liver and renal
function tests. The peripheral smear showed haemoglobin
9 mg/dl, total count of 6000/dl with normocytic normochromic via inhalation, ingestion or dermal contact. It has been shown
blood picture. The human immunodeficiency virus test (HIV), in experimental rats, that long-term inhalational exposure to
hepatitis B surface antigen (HbsAg), antibodies to hepatitis C carbon black, TiO2 and talc to produce pulmonary inflammation,
virus (anti-HCV) was negative. The chest X-ray showed right fibrosis and lung tumors.[4] The respiratory effects observed
massive pleural effusion. CT chest revealed mass in the right among groups of TiO2-exposed workers include decline in lung
middle and apical lobe with right pleural effusion [Figures function, pleural disease with plaques and pleural thickening
1a and 1b] and ultrasonography abdomen showed multiple and mild fibrotic changes (IARC monograph, volume 93).
nodular lesions in the liver suggestive of liver metastases. The
pleural fluid showed elevated protein (6 mg/dl) and cytology There have been three large cohort studies [5-7] among
of pleural fluid was suggestive of adenocarcinoma. The lung production workers in the TiO2 industry. The largest, conducted
biopsy was not done as patient refused to give consent. in six European countries, found a slightly increased risk for
lung cancer compared to the general population.[5] However,
Paint is a suspension of finely divided pigment particles in a there was no evidence of an exposure response relationship
liquid composed of a binder and a volatile solvent or water. The within the cohort. The other cohort studies,[6,7] both of which
most common pigment employed in paint is the white pigment were conducted in the USA, did not report any increased risk for
TiO2, produced from ilmenite ore or from titanium slag. TiO2 lung cancer. The recent study conducted in Montreal showed
was first produced commercially in 1923, primarily for pigment that people exposed to TiO2 did not experience any excess
production. It is primarily used as whitening and mollifying risk of lung cancer.[8] The results of the study by Siemiatycki
agent in paints, varnishes, lacquers, paper, plastics, ceramics, et al. showed possible increase in lung cancer risk among
rubber and printing ink.[3] TiO2 is generally present in paints in subjects with high exposure to TiO2.[9] The cytogenetic studies
proportions varying between 10% and 20% and probably below on painters reported increased levels of genetic damage, such
2 mg/cubic mm during most spray paint operations.[2] The spray as chromosomal aberrations, micronucleus formation, sister
painting in closed spaces without protection can lead to the chromatid exchange[10] and single strand DNA breaks.
inhalation of high concentrations of TiO2. The IARC conducts
evaluations of carcinogenic risks of different agents, and Our patient occupation was painting mainly interior
thereby provides the information base for cancer prevention painting, spray painting and primer paintings of wooden
throughout the world [Table 1].[4] According to IARC (monograph blocks and metals for more than 20 years. The predominant
volume 98, 2010) report, occupational exposure as a painter is pigment involved in most paints was TiO2. He used to work
carcinogenic to humans (Group 1). Humans are exposed to TiO2 predominantly in closed spaces without proper facemask and
Journal of Cancer Research and Therapeutics - July-September 2011 - Volume 7 - Issue 3 359
[Downloaded free from http://www.cancerjournal.net on Wednesday, April 10, 2019, IP: 36.84.243.159]
360 Journal of Cancer Research and Therapeutics - July-September 2011 - Volume 7 - Issue 3